[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts",
    "summary": "Bristol Myers Squibb (BMY) closed the most recent trading day at $59.21, moving +0.03% from the previous trading session.",
    "url": "https://finnhub.io/api/news?id=d2261824849cefb9085dbd408b25dfb27f76d88a9d095f563d9250254375b357",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743025516,
      "headline": "Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts",
      "id": 133462152,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers Squibb (BMY) closed the most recent trading day at $59.21, moving +0.03% from the previous trading session.",
      "url": "https://finnhub.io/api/news?id=d2261824849cefb9085dbd408b25dfb27f76d88a9d095f563d9250254375b357"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Merck (MRK): “I Like It at This Level – But I Like Bristol-Myers Even More!”",
    "summary": "We recently published a list of Jim Cramer Recently Put These 10 Stocks Under Spotlight. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other stocks that Jim Cramer discussed recently. On Monday, Jim Cramer, host of Mad Money, shared his thoughts on how the […]",
    "url": "https://finnhub.io/api/news?id=88cdf4020654f947642c32f12b36a0002f2f93483992fc0c041dc81148e911fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743011113,
      "headline": "Jim Cramer on Merck (MRK): “I Like It at This Level – But I Like Bristol-Myers Even More!”",
      "id": 133462083,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer Recently Put These 10 Stocks Under Spotlight. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other stocks that Jim Cramer discussed recently. On Monday, Jim Cramer, host of Mad Money, shared his thoughts on how the […]",
      "url": "https://finnhub.io/api/news?id=88cdf4020654f947642c32f12b36a0002f2f93483992fc0c041dc81148e911fa"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Says Board Chair & CEO Christopher S. Boerner's 2024 Total Compensation Was $18.8 Million - SEC Filing",
    "summary": "Bristol-Myers Squibb Co: * BRISTOL-MYERS SQUIBB SAYS BOARD CHAIR & CEO CHRISTOPHER S.BOERNER'S 2024 TOTAL COMPENSATION WAS $18.8 MILLION - SEC FILINGSource text:Further company...",
    "url": "https://finnhub.io/api/news?id=ef30687df17ee73cbaabb6cf76a52c60a1c28f7123765a58c61a2c2d3ef3f458",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743006246,
      "headline": "Bristol-Myers Squibb Says Board Chair & CEO Christopher S. Boerner's 2024 Total Compensation Was $18.8 Million - SEC Filing",
      "id": 133459567,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol-Myers Squibb Co: * BRISTOL-MYERS SQUIBB SAYS BOARD CHAIR & CEO CHRISTOPHER S.BOERNER'S 2024 TOTAL COMPENSATION WAS $18.8 MILLION - SEC FILINGSource text:Further company...",
      "url": "https://finnhub.io/api/news?id=ef30687df17ee73cbaabb6cf76a52c60a1c28f7123765a58c61a2c2d3ef3f458"
    }
  },
  {
    "ts": null,
    "headline": "1 Large-Cap Stock on Our Watchlist and 2 to Brush Off",
    "summary": "Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.",
    "url": "https://finnhub.io/api/news?id=8e047f15c8e1dbb20d38d683cfde9e5c72dd3e277a3a50221756a757d8dca1ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742994108,
      "headline": "1 Large-Cap Stock on Our Watchlist and 2 to Brush Off",
      "id": 133462154,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.",
      "url": "https://finnhub.io/api/news?id=8e047f15c8e1dbb20d38d683cfde9e5c72dd3e277a3a50221756a757d8dca1ea"
    }
  },
  {
    "ts": null,
    "headline": "The Risk/Reward Of Avidity Biosciences And Its 2 Promising Programs",
    "summary": "Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward investment. Read more on RNA stock update.",
    "url": "https://finnhub.io/api/news?id=e9c604309b041827af4cb535b2f3a76212b25575ce814704f2600525c158cd74",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742984229,
      "headline": "The Risk/Reward Of Avidity Biosciences And Its 2 Promising Programs",
      "id": 133456250,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155151969/image_155151969.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward investment. Read more on RNA stock update.",
      "url": "https://finnhub.io/api/news?id=e9c604309b041827af4cb535b2f3a76212b25575ce814704f2600525c158cd74"
    }
  }
]